Industry Insider Activity

Biotechnology insider activity

Concentrated executive and director transaction evidence across 296 companies, with acquisition/disposal balance, filing cadence, value concentration, and linked company research.

Latest filing 24 Jul 2026 7043 filings tracked

Top-level read

Net insider selling

Biotechnology shows 3651 acquisition filings against 3392 disposal filings. The largest stored filing is $1.0B in NUVL by FLYNN, JAMES E.

Net value $-3.5Bacquisitions minus disposals
Companies 296with stored filings
Total filings 7043stored transaction rows
Acquisition value $418.6M3651 acquisitions
Disposal value $3.9B3392 disposals
Largest filing $1.0Breported transaction value

Filing cadence

Last 12 active months
Mar 2026 165
Apr 2026 888
May 2026 1788
Jun 2026 2996
Jul 2026 1206

Acquisitions 51.8% · Disposals 48.2%

Company Reads

Most active company insider tapes

24 shown

Transaction Evidence

Latest filings in Biotechnology

Showing 61-90 of 7043
Date 20 Jul 2026
Symbol ANIXAnixa Biosciences Inc
Insider KUMAR, AMITDirector, Chief Executive Officer
Side Acquisition
Shares 5000
Value 17300
Industry Biotechnology
Date 20 Jul 2026
Symbol MDGLMadrigal Pharmaceuticals Inc
Insider SIBOLD, WILLIAM JOHNDirector, President and CEO
Side Disposal
Shares 1
Value 551
Industry Biotechnology
Date 20 Jul 2026
Symbol NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
Insider KOOIJ, LOUISE FREDERIKAChief Accounting Officer
Side Disposal
Shares 25000
Value 0
Industry Biotechnology
Date 20 Jul 2026
Symbol NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
Insider KOOIJ, LOUISE FREDERIKAChief Accounting Officer
Side Disposal
Shares 80000
Value 0
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider COLLARD, CRAIG ADirector, Chief Executive Officer
Side Acquisition
Shares 13797
Value -
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider DUARTE, IRAEVP, Chief Financial Officer
Side Acquisition
Shares 3874
Value -
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider FORBES, WILLIAM PEVP, Chief Development Officer
Side Acquisition
Shares 3874
Value -
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider DUARTE, IRAEVP, Chief Financial Officer
Side Disposal
Shares 1101
Value 517
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider FORBES, WILLIAM PEVP, Chief Development Officer
Side Disposal
Shares 1101
Value 517
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider COLLARD, CRAIG ADirector, Chief Executive Officer
Side Disposal
Shares 13797
Value 0
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider DUARTE, IRAEVP, Chief Financial Officer
Side Disposal
Shares 3874
Value 0
Industry Biotechnology
Date 19 Jul 2026
Symbol HRTXHeron Therapeuti
Insider FORBES, WILLIAM PEVP, Chief Development Officer
Side Disposal
Shares 3874
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol MDGLMadrigal Pharmaceuticals Inc
Insider SIBOLD, WILLIAM JOHNDirector, President and CEO
Side Acquisition
Shares 50000
Value -
Industry Biotechnology
Date 17 Jul 2026
Symbol MNKDMannKind Corp
Insider BINDER, STEVEN B.Director
Side Disposal
Shares 52485
Value 213089
Industry Biotechnology
Date 17 Jul 2026
Symbol FULCFulcrum Therapeutics Inc
Insider TANG, KEVIN10% Owner
Side Acquisition
Shares 50945
Value 179326
Industry Biotechnology
Date 17 Jul 2026
Symbol MNKDMannKind Corp
Insider THOMSON, DAVIDEVP Genl Counsel & Secretary
Side Disposal
Shares 24109
Value 97641
Industry Biotechnology
Date 17 Jul 2026
Symbol RANIRani Therapeutics Holdings Inc
Insider IMRAN, TALATDirector, Chief Executive Officer
Side Acquisition
Shares 35000
Value 25193
Industry Biotechnology
Date 17 Jul 2026
Symbol DNAGinkgo Bioworks Holdings
Insider COEN, STEVEN P.See remarks
Side Disposal
Shares 752
Value 5943
Industry Biotechnology
Date 17 Jul 2026
Symbol BCDABiocardia Inc
Insider ALTMAN, PETERDirector, President and CEO
Side Acquisition
Shares 500
Value 415
Industry Biotechnology
Date 17 Jul 2026
Symbol LYELLyell Immunopharma Inc
Insider INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD10% Owner
Side Disposal
Shares 10
Value 137
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider BLAYNEY, DOUGLASDirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider EMANUELE, ROBERT MARTINDirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider FAVORITO, TAMARA ADirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider KELLY, STEVENDirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider MATSUI, CONNIEDirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ARTLArtelo Biosciences Inc
Insider REYES, GREGORYDirector
Side Acquisition
Shares 136
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol MDGLMadrigal Pharmaceuticals Inc
Insider SIBOLD, WILLIAM JOHNDirector, President and CEO
Side Disposal
Shares 50000
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol RANIRani Therapeutics Holdings Inc
Insider MAESTAS, NICHOLASChief Financial Officer
Side Acquisition
Shares 2000000
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ROIVRoivant Sciences Ltd
Insider EPPERLY, MELISSA B,Director
Side Acquisition
Shares 543
Value 0
Industry Biotechnology
Date 17 Jul 2026
Symbol ROIVRoivant Sciences Ltd
Insider MOMTAZEE, JAMES CDirector
Side Acquisition
Shares 405
Value 0
Industry Biotechnology